Spain· ES:11731008
KOMBOGLYZE 2,5 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A medicinal product containing saxagliptina + metformina, registered in Spain by Astrazeneca Ab.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- saxagliptina + metformina
- Manufacturer
- Astrazeneca Ab
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo70058956EUR 53.87
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Saxagliptina + metformina in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaKOMBOGLYZEAstraZeneca AB, Södertälje
- United StatesSaxagliptin and MetforminMylan Pharmaceuticals Inc.
- SwitzerlandKombiglyze XR
- United KingdomKomboglyze 2.5mg/1000mg tabletsAstraZeneca UK Ltd
- CanadaKOMBOGLYZEASTRAZENECA CANADA INC
- FinlandKomboglyzeAstraZeneca AB
- NetherlandsKomboglyze 2.5 mg/1000 mg, filmomhulde tablettenAstraZeneca AB
- PolandKomboglyzeAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- France · Saxagliptine/Metformine Biogaran
- Iceland · Komboglyze
- Liechtenstein · Komboglyze
- Malta · Saxagliptin/Metformin Pharos
- Norway · Komboglyze
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/92621469-9c40-4e43-abcb-7033e0066b9b GET /v1/drugs/92621469-9c40-4e43-abcb-7033e0066b9b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1325545200000}",
"nregistro": "11731008",
"substance": "saxagliptina + metformina"
}See everything about saxagliptina + metformina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.